{"id":"doi:10.1038/nrclinonc.2016.66","kind":"review","title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","authors":["Giampaolo Bianchini","Justin Micah Balko","Ingrid A. Mayer","Melinda E. Sanders","Luca Gianni"],"author_count":5,"year":2016,"published":"2016-05-17","venue":"Nature Reviews Clinical Oncology","cited_by":3073,"doi":"10.1038/nrclinonc.2016.66","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/nrclinonc.2016.66","archive_url":"https://space-kitty.com/papers/doi:10.1038/nrclinonc.2016.66","updated":null,"pmid":"27184417","pmcid":null,"openalex_id":"W2402636472","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Breast Cancer Treatment Studies"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}